critical appraisal of journals
TRANSCRIPT
-
8/3/2019 Critical Appraisal of Journals
1/24
Rafael Lorenz Santos
-
8/3/2019 Critical Appraisal of Journals
2/24
-
8/3/2019 Critical Appraisal of Journals
3/24
-
8/3/2019 Critical Appraisal of Journals
4/24
-
8/3/2019 Critical Appraisal of Journals
5/24
Guide Questions
Are your issues discussed there?
-Yes.
Do you want to know more after reading thisabstract?
-Yes. Was the research done in a similar setting to yours?
-No.
Does it address a related question?
-Yes.
Are there reasons to doubt without reading the wholearticle?
-None.
-
8/3/2019 Critical Appraisal of Journals
6/24
-
8/3/2019 Critical Appraisal of Journals
7/24
-
8/3/2019 Critical Appraisal of Journals
8/24
Guide Questions
Compare the abstract to the discussionsection
-N/A
Compare the raw data contained in thetables to the results in the Discussions andConclusions sections.
-N/A
How well are the results related to otherresearch regarding the topic?
-N/A
-
8/3/2019 Critical Appraisal of Journals
9/24
-
8/3/2019 Critical Appraisal of Journals
10/24
-
8/3/2019 Critical Appraisal of Journals
11/24
Guide Questions
Are all the relevant factors included in the research?
-Yes.
How important are the variables that may have beenleft out?
-In doing a research, every information about thetopic should be indicated and discussed becausethey are all essential. If a variable is left out, theresearch would be incomplete and insufficientinformation will be presented.
How good are the measure?
-The measures used in the research are well-established and were vastly used in priorresearches.
How good is the data?
-The data is presented in a well-defined manner.
-
8/3/2019 Critical Appraisal of Journals
12/24
Guide Questions
How similar or different are the groups being compared?
-The product being discussed in this research is said to be morecost-effective than the other conventional therapies.
Is there a risk of selection bias?
-Yes.
What was the reason the research was done?-To compare Rosiglitazone with other oral hypoglycemic agentsfor the treatment of Type 2 Diabetes Mellitus.
Is the sample large enough to produce significant results? Is theeffect size clinically or operationally relevant?
-Yes.
-Yes. Is there a discussion of how the methods relate to those used in
other studies?
-Yes.
-
8/3/2019 Critical Appraisal of Journals
13/24
-
8/3/2019 Critical Appraisal of Journals
14/24
Guide Questions
Did the review explicitly address thepublic health question?
-Yes.
Was the search for relevant studiesdetailed and exhaustive?
-Yes.
Were the primary studies of highmethodological quality?
-Yes.
-
8/3/2019 Critical Appraisal of Journals
15/24
-
8/3/2019 Critical Appraisal of Journals
16/24
-
8/3/2019 Critical Appraisal of Journals
17/24
-
8/3/2019 Critical Appraisal of Journals
18/24
-
8/3/2019 Critical Appraisal of Journals
19/24
-
8/3/2019 Critical Appraisal of Journals
20/24
Guide Questions
Are your issues discussed there?
-Yes.
Do you want to know more after reading thisabstract?
-Yes. Was the research done in a similar setting to yours?
-No.
Does it address a related question?
-Yes.
Are there reasons to doubt without reading the wholearticle?
-None.
-
8/3/2019 Critical Appraisal of Journals
21/24
-
8/3/2019 Critical Appraisal of Journals
22/24
-
8/3/2019 Critical Appraisal of Journals
23/24
Guide Questions
Compare the abstract to the discussionsection
-The discussion section included thelimitations concerning the study.
Compare the raw data contained in thetables to the results in the Discussions andConclusions sections.
-The data in the tables and in the
discussions and conclusions sections areconsistent and are connected to eachother.
-
8/3/2019 Critical Appraisal of Journals
24/24